Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

Journal of Thoracic Oncology

Volumn 14, Issue 10, 2019, Pages 1732-1742

[No Author Info available]

Author keywords

Incidence; Low dose CT; Lung cancer; Mortality; Screening

Indexed keywords

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LARGE CELL LUNG CARCINOMA; LOW DOSE COMPUTED TOMOGRAPHY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; SQUAMOUS CELL LUNG CARCINOMA; THORAX RADIOGRAPHY; EARLY CANCER DIAGNOSIS; INCIDENCE; LARGE CELL CARCINOMA; LUNG TUMOR; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SMALL CELL LUNG CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UNITED STATES;

ADENOCARCINOMA OF LUNG; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; UNITED STATES;

EID: 85070069030     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2019.05.044     Document Type: Article

References (25)

1. World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed October 10, 2018.
2. Naidch DP, Marshall CH, Gribbin C, Arams RS, McCauley DI. Low-dose CT of the lungs: preliminary observations. Radiology. 1990;175:729-731.
3. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology. 1996;201:798-802
4. Aberle DR, Berg CD, Black WC, et al. The National Lung Screening Trial: overview and study design. Radiology. 2011;258:243-253.
5. The National Lung Screening Trial Research Team, Aberle DR, Adams EM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
6. Paci E, Puliti D, Pegna AL, et al. Mortality, survival and incidence rates in the ITALUNG randomized lung cancer screening trial. Thorax. 2017;72:825-831.
7. Infante M, Cavuto S, Lutman FR, et al. Long-term follow-up results of the DANTE Trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Resp Crit Care Med. 2015;191:1166-1175.
8. Wille MW, Dirksen A, Ashraf H, et al. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Resp Crit Care Med. 2016;193:54-551.
9. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21:308-315.
10. Doroudi M, Pinsky PF, Marcus PM. Lung cancer mortality in the Lung Screening Study (LSS) feasibility trial [e-pub ahead of print]. JNCI Cancer Spectr. doi:10.1093/jncics/pky042, accessed
11. De Koning H. Mortality results of the NELSON randomized controlled population-based screening trial. Paper presented at: IASLC 19th World Conference on Lung Cancer. September 23–26, 2018; Toronto, Canada.
12. Patz E, Pinsky PF, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174:269-274.
13. Etzioni R, Self SG. On the catch-up time method for analyzing cancer screening trials. Biometrics. 1995;51:31-43.
14. Prorok PC, Aron JL. An analysis of the mortality effect in a breast cancer screening study. Int J Epidemiol. 1986;15:36-43.
15. Nelson HD, Fu R, Cantor A, et al. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2016;164:244-255.
16. Hanley J. Analysis of mortality data from cancer screening studies: looking in the right window. Epidemiology. 2005:16:786-790.
17. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history and lung cancer histology. Cancer. 2013;119:3976-3983.
18. De Koning H, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:311-320.
19. McMahon PM, Meza, R, Plevritis SK, et al. Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. PLoS One. 2014;9:e99978.
20. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:24-248.
21. Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors. J Thorac Oncol. 2015;10:1243-1260.
22. Heleno BN, Siersma V, Brodersen J. Estimation of overdiagnosis of lung cancer in low-dose computed tomography screening: a secondary analysis of the Danish Lung Cancer Screening Trial. JAMA Intern Med. 2018;178:1420-1422.
23. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol. 2017;3:1278-1281.
24. Huo J, Shen C, Volk RJ, Shih, Y. Use of CT and chest radiography for lung cancer screening before and after publication of screening guidelines: intended and unintended uptake. JAMA Intern Med. 2017;177:439-441.
25. Marcus PM, Doria-Rose VP, Gareen IF, et al. Did death certificates and a death review process agree on lung cancer cause of death in The National Lung Screening Trial? Clin Trials. 2016;13:434-438.